Patients with acute coronary syndrome (ACS) or who undergo percutaneous coronary intervention (PCI) require dual antiplatelet therapy (DAPT) with aspirin and a P2Y12 inhibitor to prevent myocardial infarction (MI) and stent thrombosis (1). Here, P2RY12 is linked to myocardial infarction.